148 related articles for article (PubMed ID: 30792230)
1. GLP-1 signaling suppresses menin's transcriptional block by phosphorylation in β cells.
Xing B; Ma J; Jiang Z; Feng Z; Ling S; Szigety K; Su W; Zhang L; Jia R; Sun Y; Zhang L; Kong X; Ma X; Hua X
J Cell Biol; 2019 Mar; 218(3):855-870. PubMed ID: 30792230
[TBL] [Abstract][Full Text] [Related]
2. Stimulation of pancreatic beta-cell replication by incretins involves transcriptional induction of cyclin D1 via multiple signalling pathways.
Friedrichsen BN; Neubauer N; Lee YC; Gram VK; Blume N; Petersen JS; Nielsen JH; Møldrup A
J Endocrinol; 2006 Mar; 188(3):481-92. PubMed ID: 16522728
[TBL] [Abstract][Full Text] [Related]
3. Menin and PRMT5 suppress GLP1 receptor transcript and PKA-mediated phosphorylation of FOXO1 and CREB.
Muhammad AB; Xing B; Liu C; Naji A; Ma X; Simmons RA; Hua X
Am J Physiol Endocrinol Metab; 2017 Aug; 313(2):E148-E166. PubMed ID: 28270438
[TBL] [Abstract][Full Text] [Related]
4. Glucagon-like peptide-1 improves beta-cell antioxidant capacity via extracellular regulated kinases pathway and Nrf2 translocation.
Fernández-Millán E; Martín MA; Goya L; Lizárraga-Mollinedo E; Escrivá F; Ramos S; Álvarez C
Free Radic Biol Med; 2016 Jun; 95():16-26. PubMed ID: 26968794
[TBL] [Abstract][Full Text] [Related]
5. Anti-diabetic actions of glucagon-like peptide-1 on pancreatic beta-cells.
Lee YS; Jun HS
Metabolism; 2014 Jan; 63(1):9-19. PubMed ID: 24140094
[TBL] [Abstract][Full Text] [Related]
6. Synergistic effect of dimethyl sulfoxide on glucagon-like peptide 1 (GLP-1)-stimulated insulin secretion and gene transcription in INS-1 cells: characterization and implications.
Kemp DM; Habener JF
Biochem Pharmacol; 2002 Aug; 64(4):689-97. PubMed ID: 12167488
[TBL] [Abstract][Full Text] [Related]
7. Glucagon-like peptide-1 prevents methylglyoxal-induced apoptosis of beta cells through improving mitochondrial function and suppressing prolonged AMPK activation.
Chang TJ; Tseng HC; Liu MW; Chang YC; Hsieh ML; Chuang LM
Sci Rep; 2016 Mar; 6():23403. PubMed ID: 26997114
[TBL] [Abstract][Full Text] [Related]
8. GLP-1(28-36) improves β-cell mass and glucose disposal in streptozotocin-induced diabetic mice and activates cAMP/PKA/β-catenin signaling in β-cells in vitro.
Shao W; Wang Z; Ip W; Chiang YT; Xiong X; Chai T; Xu C; Wang Q; Jin T
Am J Physiol Endocrinol Metab; 2013 Jun; 304(12):E1263-72. PubMed ID: 23571712
[TBL] [Abstract][Full Text] [Related]
9. Glucagon-like peptide 1 stimulates insulin gene promoter activity by protein kinase A-independent activation of the rat insulin I gene cAMP response element.
Skoglund G; Hussain MA; Holz GG
Diabetes; 2000 Jul; 49(7):1156-64. PubMed ID: 10909973
[TBL] [Abstract][Full Text] [Related]
10. GLP-1 signalling compensates for impaired insulin signalling in regulating beta cell proliferation in βIRKO mice.
Kawamori D; Shirakawa J; Liew CW; Hu J; Morioka T; Duttaroy A; Burkey B; Kulkarni RN
Diabetologia; 2017 Aug; 60(8):1442-1453. PubMed ID: 28526921
[TBL] [Abstract][Full Text] [Related]
11. NFAT regulates insulin gene promoter activity in response to synergistic pathways induced by glucose and glucagon-like peptide-1.
Lawrence MC; Bhatt HS; Easom RA
Diabetes; 2002 Mar; 51(3):691-8. PubMed ID: 11872668
[TBL] [Abstract][Full Text] [Related]
12. Oleoyl-lysophosphatidylinositol enhances glucagon-like peptide-1 secretion from enteroendocrine L-cells through GPR119.
Arifin SA; Paternoster S; Carlessi R; Casari I; Ekberg JH; Maffucci T; Newsholme P; Rosenkilde MM; Falasca M
Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Sep; 1863(9):1132-1141. PubMed ID: 29883799
[TBL] [Abstract][Full Text] [Related]
13. Glucagon-Like Peptide-1 Regulates Cholecystokinin Production in β-Cells to Protect From Apoptosis.
Linnemann AK; Neuman JC; Battiola TJ; Wisinski JA; Kimple ME; Davis DB
Mol Endocrinol; 2015 Jul; 29(7):978-87. PubMed ID: 25984632
[TBL] [Abstract][Full Text] [Related]
14. Low, but physiological, concentration of GLP-1 stimulates insulin secretion independent of the cAMP-dependent protein kinase pathway.
Shigeto M; Katsura M; Matsuda M; Ohkuma S; Kaku K
J Pharmacol Sci; 2008 Nov; 108(3):274-9. PubMed ID: 18987435
[TBL] [Abstract][Full Text] [Related]
15. Glucagon-Like Peptide 1 Increases β-Cell Regeneration by Promoting α- to β-Cell Transdifferentiation.
Lee YS; Lee C; Choung JS; Jung HS; Jun HS
Diabetes; 2018 Dec; 67(12):2601-2614. PubMed ID: 30257975
[TBL] [Abstract][Full Text] [Related]
16. Menin and MLL cooperatively regulate expression of cyclin-dependent kinase inhibitors.
Milne TA; Hughes CM; Lloyd R; Yang Z; Rozenblatt-Rosen O; Dou Y; Schnepp RW; Krankel C; Livolsi VA; Gibbs D; Hua X; Roeder RG; Meyerson M; Hess JL
Proc Natl Acad Sci U S A; 2005 Jan; 102(3):749-54. PubMed ID: 15640349
[TBL] [Abstract][Full Text] [Related]
17. Glucagon-like peptide-1 stimulates type 3 iodothyronine deiodinase expression in a mouse insulinoma cell line.
Akiyama S; Ogiwara T; Aoki T; Tsunekawa K; Araki O; Murakami M
Life Sci; 2014 Oct; 115(1-2):22-8. PubMed ID: 25241124
[TBL] [Abstract][Full Text] [Related]
18. Glucagon-like peptide-1 attenuates endothelial barrier injury in diabetes via cAMP/PKA mediated down-regulation of MLC phosphorylation.
Tang ST; Tang HQ; Su H; Wang Y; Zhou Q; Zhang Q; Wang Y; Zhu HQ
Biomed Pharmacother; 2019 May; 113():108667. PubMed ID: 30852419
[TBL] [Abstract][Full Text] [Related]
19. Glucagon-like peptide 1-potentiated insulin secretion and proliferation of pancreatic β-cells.
Ma X; Guan Y; Hua X
J Diabetes; 2014 Sep; 6(5):394-402. PubMed ID: 24725840
[TBL] [Abstract][Full Text] [Related]
20. Menin Upregulates FOXO1 Protein Stability by Repressing Skp2-Mediated Degradation in β Cells.
Jiang Z; Xing B; Feng Z; Ma J; Ma X; Hua X
Pancreas; 2019 Feb; 48(2):267-274. PubMed ID: 30629029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
